| Lessons in self-defence: inhibition of virus entry by intrinsic immunity S Majdoul, AA Compton Nature Reviews Immunology 22 (6), 339-352, 2022 | 79 | 2022 |
| Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state K Rahman, CA Coomer, S Majdoul, SY Ding, S Padilla-Parra, ... Elife 9, e58537, 2020 | 53 | 2020 |
| Molecular determinants of vectofusin-1 and its derivatives for the enhancement of lentivirally mediated gene transfer into hematopoietic stem/progenitor cells S Majdoul, AK Seye, A Kichler, N Holic, A Galy, B Bechinger, D Fenard Journal of Biological Chemistry 291 (5), 2161-2169, 2016 | 43 | 2016 |
| Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of … D Ingrao, S Majdoul, AK Seye, A Galy, D Fenard Human gene therapy methods 25 (1), 48-56, 2014 | 35 | 2014 |
| Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles LS Vermeer, L Hamon, A Schirer, M Schoup, J Cosette, S Majdoul, ... Acta Biomaterialia 64, 259-268, 2017 | 34 | 2017 |
| Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2 G Shi, AI Chiramel, T Li, KK Lai, AD Kenney, A Zani, AC Eddy, S Majdoul, ... The Journal of Clinical Investigation 132 (24), 2022 | 31 | 2022 |
| IFITM3 reduces retroviral envelope abundance and function and is counteracted by glycoGag YS Ahi, D Yimer, G Shi, S Majdoul, K Rahman, A Rein, AA Compton MBio 11 (1), 10.1128/mbio. 03088-19, 2020 | 27 | 2020 |
| Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors N Holic, AK Seye, S Majdoul, S Martin, OW Merten, A Galy, D Fenard Human gene therapy Clinical development 25 (3), 178-185, 2014 | 26 | 2014 |
| Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells S Majdoul, J Cosette, AK Seye, E Bernard, S Frin, N Holic, N Chazal, ... Journal of Biological Chemistry 292 (45), 18672-18681, 2017 | 10 | 2017 |
| Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid A Moussy, N Papili Gao, G Corre, V Poletti, S Majdoul, D Fenard, ... Human gene therapy 30 (8), 1023-1034, 2019 | 8 | 2019 |
| Restriction of influenza A virus by SERINC5 KK Lai, JB Munro, G Shi, S Majdoul, AA Compton, A Rein MBio 13 (6), e02923-22, 2022 | 5 | 2022 |
| IFITM3 reduces retroviral envelope abundance and function and is counteracted by glycoGag. mBio 11: e03088-19 YS Ahi, D Yimer, G Shi, S Majdoul, K Rahman, A Rein, AA Compton | 5 | 2020 |
| Compositions and methods for improving viral vector efficiency S Majdoul, D Fenard US Patent 11,371,061, 2022 | 1 | 2022 |
| Generation of Hinge-Modified Human CD19 Chimeric Antigen Receptor (CAR) T Cells for the Treatment of CD19-Low Leukemia VM Giordani, J Mirazee, M Pouzolles, M Benzaoui, CD Chien, S Majdoul, ... Blood 142, 6819, 2023 | | 2023 |
| Compositions and methods for improving viral vector efficiency S Majdoul, D Fenard US Patent App. 17/750,705, 2023 | | 2023 |
| Select Rapamycin Analogs Promote VSV-G-Mediated Cell Entry by Activating TFEB-Dependent Microautophagy G Shi, S Majdoul, AA Compton MOLECULAR THERAPY 30 (4), 531-531, 2022 | | 2022 |
| Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2 (preprint) G Shi, AI Chiramel, S Majdoul, KK Lai, S Das, PA Beare, T Andresson, ... | | 2021 |
| Etude et développement de nouveaux additifs peptidiques capables de promouvoir l’entrée des vecteurs lentiviraux de thérapie génique dans les cellules cibles S Majdoul Université Paris-Saclay (ComUE), 2016 | | 2016 |
| Relief of a strong entry restriction exerted on lentiviral vectors using Tat-Beclin1 peptide S Majdoul, AK Seye, S Frin, N Holic, A Galy, D Fenard HUMAN GENE THERAPY 27 (11), A111-A111, 2016 | | 2016 |
| 536. The Viral Transduction Enhancer Vectofusin-1 Is a Nanofibrillar Peptide Capable of Increasing the Contact between Viral Vectors and Target Cells S Majdoul, L Vermeer, L Hamon, J Wolf, AK Seye, N Holic, D Pastre, ... Molecular Therapy 24, S214, 2016 | | 2016 |
David FenardExecutive / Senior Director - R&D / Cell Engineering, Sangamo TherapeuticsVerified email at sangamo.com
